Patent details

EP2645997 Title: ONCE DAILY FORMULATION OF LACOSAMIDE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2645997
WO Application Number:
EP2011006027
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11791442.4
WO Publication Number:
WO2012072256
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
01/12/2011
Grant date:
10/08/2022
EP Publication Date:
09/10/2013
WO Publication Date:
07/06/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/08/2022
EP B1 Publication Date:
10/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/11/2031
Lapsed By Expiration Date:
Revocation Date:
16/05/2024
Invalidity Date:
10/08/2022
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
10/08/2022
 
 

 

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 MONHEIM, Germany (DE)

Inventor

1

Name:
CAWELLO, Willi
Address:
40789 Monheim, Germany (DE)

2

Name:
SCHUBERT, Martin, Alexander
Address:
38126 Braunschweig, Germany (DE)

Priority

1

Priority Patent Number:
201161485354 P
Priority Date:
12/05/2011
Priority Country:
United States of America (US)

2

Priority Patent Number:
201161485361 P
Priority Date:
12/05/2011
Priority Country:
United States of America (US)

3

Priority Patent Number:
201161444447 P
Priority Date:
18/02/2011
Priority Country:
United States of America (US)

4

Priority Patent Number:
201161444439 P
Priority Date:
18/02/2011
Priority Country:
United States of America (US)

5

Priority Patent Number:
419158 P
Priority Date:
02/12/2010
Priority Country:
United States of America (US)

6

Priority Patent Number:
419153 P
Priority Date:
02/12/2010
Priority Country:
United States of America (US)

7

Priority Patent Number:
10193559
Priority Date:
02/12/2010
Priority Country:
European Patent Office (EPO) (EP)

8

Priority Patent Number:
10193561
Priority Date:
02/12/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/50; A61K 9/16; A61K 9/20; A61K 9/28; A61K 31/165; A61P 25/00; A61P 25/08; A61P 25/14; A61P 25/18;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
50/22
Publication date:
14/12/2022
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
32/22
Publication date:
10/08/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202441
Publication date:
09/10/2024
Description:
Revocation of the European patent

2

Issue number:
202232
Publication date:
10/08/2022
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type